ATE123060T1 - Tgf-beta induziertes gen und protein. - Google Patents

Tgf-beta induziertes gen und protein.

Info

Publication number
ATE123060T1
ATE123060T1 AT93300809T AT93300809T ATE123060T1 AT E123060 T1 ATE123060 T1 AT E123060T1 AT 93300809 T AT93300809 T AT 93300809T AT 93300809 T AT93300809 T AT 93300809T AT E123060 T1 ATE123060 T1 AT E123060T1
Authority
AT
Austria
Prior art keywords
tgf
protein
beta
gene
induced gene
Prior art date
Application number
AT93300809T
Other languages
English (en)
Inventor
Anthony F Purchio
Michael G Neubauer
John E Skonier
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE123060T1 publication Critical patent/ATE123060T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93300809T 1992-02-05 1993-02-04 Tgf-beta induziertes gen und protein. ATE123060T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83383592A 1992-02-05 1992-02-05

Publications (1)

Publication Number Publication Date
ATE123060T1 true ATE123060T1 (de) 1995-06-15

Family

ID=25265395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93300809T ATE123060T1 (de) 1992-02-05 1993-02-04 Tgf-beta induziertes gen und protein.

Country Status (8)

Country Link
US (1) US5444164A (de)
EP (1) EP0555989B1 (de)
JP (1) JPH07133296A (de)
AT (1) ATE123060T1 (de)
CA (1) CA2088804A1 (de)
DE (1) DE69300158T2 (de)
DK (1) DK0555989T3 (de)
ES (1) ES2073327T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2162586C (en) 1993-05-13 2006-01-03 David J. Grainger Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
CA2175380A1 (en) * 1993-10-29 1995-05-04 Lan Bo Chen A novel tumor marker and novel method of isolating same
US5599788A (en) * 1994-07-01 1997-02-04 Advanced Tissue Sciences Method for accelerating skin wound healing with H3 protein
JPH11510479A (ja) 1995-06-07 1999-09-14 ネオルックス コーポレイション タモキシフェン類似体による心臓血管疾病の予防及び治療
US5981217A (en) * 1995-12-11 1999-11-09 Mayo Foundation For Medical Education And Research DNA encoding TGF-β inducible early factor-1 (TIEF-1), a gene expressed by osteoblasts
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
US6218360B1 (en) * 1998-11-19 2001-04-17 The Schepens Eye Research Institute Collagen based biomaterials and methods of preparation and use
KR100388935B1 (ko) * 1999-10-18 2003-06-25 주식회사 리젠 바이오텍 재조합 βｉｇ-ｈ3 단백질 및 그 제조방법
KR100382042B1 (ko) * 2000-05-13 2003-05-01 주식회사 리젠 바이오텍 창상 치료를 위한 βｉｇ-ｈ3 단백질 또는 그의 일부도메인을 포함하는 약학적 조성물
KR100378949B1 (ko) * 2000-05-13 2003-04-08 주식회사 리젠 바이오텍 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체
KR100385293B1 (ko) 2000-05-13 2003-05-23 주식회사 리젠 바이오텍 βｉｇ-ｈ3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법
WO2001092578A2 (en) * 2000-05-26 2001-12-06 Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by retinoids
KR100609006B1 (ko) * 2001-04-19 2006-08-09 김인산 βｉｇ­ｈ３ 단백질의 정량방법 및 이를 이용한 진단킷트
US20030211141A1 (en) * 2001-12-11 2003-11-13 Lebaron Richard G. Genetic and protein manipulation of betaIG-H3 for the treatment and cure of muscular dystrophies
BR0215700A (pt) * 2002-04-19 2005-05-03 Regen Biotech Inc Método para medir a quantidade de proteìna de beta ig-h3 e kit diagnóstico empregando o mesmo
AU2003251646A1 (en) * 2002-07-26 2004-02-23 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Use of tgf beta ig-h3 for preventing and treating obesity, diabetes and/or metabolic syndrome
KR100481796B1 (ko) * 2002-10-02 2005-04-11 경북대학교 산학협력단 섬유아세포의 αｖβ5 인테그린과 특이적으로 결합하는βｉｇ-ｈ3 단백질 유래 펩타이드
KR100489731B1 (ko) * 2002-10-02 2005-05-16 경북대학교 산학협력단 피브로넥틴 및 βｉｇ-ｈ3의 일부 도메인을 포함하는 재조합 단백질을 함유하는 창상치료, 세포부착, 이동 및 증식 촉진용 약학적 조성물
KR100568755B1 (ko) * 2003-04-03 2006-04-07 주식회사 리젠 바이오텍 Ｙｈ 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제
US20080274955A1 (en) * 2004-04-13 2008-11-06 Kyungpook National University Industry Academic Cooperation Foundation Novel Use of a Polypeptide Comprising Fas-1 Domain

Also Published As

Publication number Publication date
US5444164A (en) 1995-08-22
CA2088804A1 (en) 1993-08-06
ES2073327T3 (es) 1995-08-01
JPH07133296A (ja) 1995-05-23
DK0555989T3 (da) 1995-07-24
DE69300158D1 (de) 1995-06-29
EP0555989B1 (de) 1995-05-24
EP0555989A1 (de) 1993-08-18
DE69300158T2 (de) 1995-10-19

Similar Documents

Publication Publication Date Title
ATE123060T1 (de) Tgf-beta induziertes gen und protein.
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
DE3751922D1 (de) Herstellung und Verwendung von IL-6
FI831818A0 (fi) Mikrobiologiskt framstaellda - och -interferoner, dessa interferoner kodande dna-sekvenser, dennagenetiska information innehaollande mikroorganismer och deras framstaellningsfoerfarande
NO911688D0 (no) Neurotrophin-3, en ny neurotrofisk faktor relatert til neurovekstfaktor og hjerne-avledet neurotrofisk faktor.
DK0601360T3 (da) B-stamcellestimulerende faktor
DE3689495D1 (de) TGF-beta codierende Nucleinsäure und deren Verwendungen.
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
ATE121776T1 (de) Expression des biologisch aktiven faktors xiii.
DK0666914T3 (da) Hidtil ukendt P-selectin-ligandprotein
DE3853023D1 (de) Produktion von Kallikrein.
NO177270C (no) Fremg. for fremstilling av terapeutisk aktive, humane granulocytt-makrofag-"kolonistimulerende"-faktorproteiner (GM-CSF), bakteriell ekspresjonvektor som er i stand til å uttrykke GM-CSF samt bakteriecelle inneholdende vektoren
ATE134219T1 (de) Menschliches mk gen und protein-sequenz
DE59810198D1 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE3777367D1 (de) Hirudin-variante, deren verwendung und herstellung.
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DK145988D0 (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
RU93058612A (ru) Клонирование и экспрессия автоантигенов декарбоксилазы глутаминовой кислоты островковых клеток человека

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee